SCHEMBL3767553

SCHEMBL3767553

O=C(C=Cc1cccc2ccccc12)N1CCN(CC(=O)N2CCN(C3CCC3)CC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 1/20 0.54
PARP1 P09874 2/20 0.49
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SIGMAR1 Q99720 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
RGS12 O14924 1/20 0.40
ACACB O00763 1/20 0.40
ACACA Q13085 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3767551 1.00 KDM4E (0.54) KDM4ENPC1RAB9APARP1ALDH1A1
SCHEMBL4378578 0.88 KDM4E (0.64) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL13636362 0.88 KDM4E (0.64) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL4376224 0.87 KDM4E (0.62) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL13636004 0.87 KDM4E (0.62) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL4384269 0.87 KDM4E (0.62) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL3803380 0.86 C3AR1 (0.47) KDM4EPARP1ALDH1A1MAPTL3MBTL1
SCHEMBL3769370 0.86 L3MBTL1 (0.60) KDM4ENPC1PARP1ALDH1A1MAPT
SCHEMBL3803381 0.86 C3AR1 (0.47) KDM4EPARP1ALDH1A1MAPTL3MBTL1
SCHEMBL3769364 0.86 L3MBTL1 (0.60) KDM4ENPC1PARP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 KDM4E 534/4885NPC1 3462/4885RAB9A 3824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.